Search

everythinglearnresearchcommunity

for

Search:↓

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

Fibre optic confocal imaging can visualize skin layers, blood vessels, and nerves in live mice.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

A rapid screening method using trichoscopy and clinical data can improve diagnosis and treatment of tinea capitis.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Dermoscopy can help diagnose tinea capitis but should be used with other tests.

UV light makes skin signs of lack of carotene and vitamin A more visible.

Sintilimab treatment caused hair loss but led to complete tumor remission.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

Majocchi’s granuloma should be considered when rashes don't improve with typical treatments.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Reflectance confocal microscopy helped diagnose and manage a woman's hair loss without needing a biopsy.

KAP-depleted hair causes less immune response and is more biocompatible for implants.

A new compound from Royoporus badius activates immune cells and induces inflammatory responses.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Immunocompromised patients can develop skin and hair issues due to a virus.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.